강원대 정현석, 을지대 문지영, 카이스트 김필한 교수와 중앙연계 김상범의 공동 연구 논문, JCB의 Spotlight로 선정

강원대 정현석, 을지대 문지영, 카이스트 김필한 교수와 중앙연계 김상범이 공동 연구한 논문이 THE JOURNAL OF CELL BIOLOGY의 Spotlight로 선정되었습니다.

 

KRS: A cut away from release in exosomes

Cancer cells often trigger an inflammatory process, which in some cases may be driven by the presence of lysyl-tRNA synthetase (KRS) in the medium. Kim et al. (2017. J. Cell Biol.https://doi.org/10.1083/jcb.201605118) now demonstrate that cleavage of the KRS by caspase-8 inside cells triggers its interaction with syntenin and its release in inflammatory exosomes.

Aminoacyl-tRNA synthetases (ARSs) are intriguing enzymes. Intracellularly, they catalyze the covalent attachment of amino acids to tRNAs and are key regulators of protein translation. However, these housekeeping enzymes have many other tricks up their sleeves. In the cell, several ARSs are also able to regulate gene expression at the level of transcription, splicing, and translation but via noncatalytic and unique mechanisms. ARSs also have different functions in the extracellular space, where they can elicit cytokine signaling responses that control angiogenesis, induce immune and proinflammatory gene expression programs, and trigger cell migration or apoptosis. The response elicited by particular ARSs is specific to the target cells (Son et al., 2014). For instance, when present in the extracellular medium, lysyl-tRNA synthetase (KRS) binds to macrophages and monocytes and activates MAPK signaling pathways that induce macrophage migration and TNF production (Park et al., 2005). How ARSs are released to the extracellular medium to carry out these activities is unknown. ARSs do not contain a signal peptide, and pharmacological agents blocking secretion through the secretory pathway have no effect on the amount of ARS in the medium. For a while, the presence of ARSs in the extracellular medium was thus thought to be caused by their passive release from cells that have undergone necrosis. In this issue, Kim et al. reinvestigate how KRS is released from cancer cells and find that this occurs through a caspase-8– and syntenin-dependent incorporation of KRS in exosomes.

http://jcb.rupress.org/content/early/2017/06/15/jcb.201706039

17 KRS synopsis_jcb.201706039

Related Post

2012.03.27 Biocon 일동제약 협약식
views 218
Biocon과 일동제약이 3월 27일 일동제약 회의실에서 GRS 공동 연구를 위한 협약식을 가졌습니다.  
의약바이오컨버젼스연구단 마케팅 직원 채용...
views 140
<서울대학교 의약바이오컨버젼스연구단 마케팅 직원 채용>   미래창조과학부 글로벌프론티어 연구개발사업의 일환으로, 혁신을 통하여 신약개발의 새로운 파라다임을 제시하고자 출범한 서울대학교 의약바이오컨버젼스연구단에서 생명과학관련 연구용 소재 및 서비스 판...
의약바이오컨버젼스연구단 박사급 연구원 채용...
views 129
<서울대학교 의약바이오컨버젼스연구단 박사급 연구원 채용> 미래창조과학부 글로벌프론티어 연구개발사업의 일환으로, 혁신을 통하여 신약개발의 새로운 파라다임을 제시하고자 출범한 서울대학교 의약바이오컨버젼스연구단에서 아래와 같은 업무를 수행할 수 있는 성실하고 책임...
(재)의약바이오컨버젼스연구단 Project Landscaping System 구축 입찰 공...
views 114
1. 일반사항 가. 입찰방식 : 일반경쟁입찰 (협상에 의한 계약) 나. 공고명 : (재)의약바이오컨버젼스연구단 Project Landscaping System 구축 다. 예산금액 : 150,000,000원(부가가치세 포함) 라. 용역기간 :...
0 Comments

Leave a reply

Your email address will not be published. Required fields are marked *

*

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you, asap.

Sending

©2010-2017 Medicinal Bioconvergence Research Center. All rights reserved.

Log in with your credentials

Forgot your details?

Skip to toolbar